ESPR - Esperion Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ESPR is currently covered by 5 analysts with an average price target of $5.16. This is a potential upside of $1.98 (62.26%) from yesterday's end of day stock price of $3.18.

Esperion Therapeutics's activity chart (see below) currently has 234 price targets and 238 ratings on display. The stock rating distribution of ESPR is 85.71% BUY and 14.29% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.38% with an average time for these price targets to be met of 138.78 days.

Highest price target for ESPR is $9, Lowest price target is $1.78, average price target is $5.16.

Most recent stock forecast was given by from NEEDHAM on 04-May-2026.

Currently out of the existing stock ratings of ESPR, 6 are a BUY (85.71%), 1 are a SELL (14.29%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Dec-2021

$5

5 months 9 days ago
(04-May-2026)

1/12 (8.33%)

$2.09 (71.82%)

205

Buy Since 11-Mar-2022

$3.16

$-0.01 (-0.32%)

$16

5 months 12 days ago
(01-May-2026)

1/8 (12.5%)

$0.05 (1.61%)

46

Sell Since 16-Mar-2026

$1.78

$-1.4 (-44.03%)

$2.5

6 months 27 days ago
(16-Mar-2026)

2/4 (50%)

$-0.91 (-33.83%)

29

Buy Since 11-Nov-2015

$5

$1.83 (57.73%)

$4

7 months ago
(13-Mar-2026)

2/13 (15.38%)

$2.56 (104.92%)

464

Buy Since 25-Nov-2025

$9

$5.82 (183.02%)

10 months 18 days ago
(25-Nov-2025)

0/1 (0%)

$5.31 (143.90%)

Show more analysts

Please expand the browser size to see the chart

What is ESPR (Esperion Therapeutics) average time for price targets to be met?

On average it took 139 days for the stock forecasts to be reached, with an average price target met ratio of 37.38%.

Which analyst most recently updated their price target on ESPR (Esperion Therapeutics)?

Which analyst has the most public recommendations on ESPR (Esperion Therapeutics)?

has 0 price targets and 0 ratings on ESPR

Which analyst is the currently most bullish on ESPR (Esperion Therapeutics)?

Chris Shibutani with the highest potential upside of $90.82

Which analyst is the currently most reserved on ESPR (Esperion Therapeutics)?

Jason Zemansky with the lowest potential downside of -$1.4
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?